GlassScriptPhysician profile
Daphne Chiu
NPI 1104562495
$12,428.18
in general payments reported to CMS, 2019-2025
57 companies · $3,179 in 2025
The $3,179 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,695 · 2023: $3,984 · 2024: $3,570 · 2025: $3,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $72.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,660.20 |
| Education | $72.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,532.84 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,276.80 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $778.74 | 2022-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $761.19 | 2023-2025 | |
| Ucb, INC. | $724.47 | 2022-2025 | Zilbrysq, Nayzilam, Rystiggo |
| Mdd US Operations, LLC | $631.32 | 2022-2025 | Gocovri, Gocovri, Qelbree |
| Ge Healthcare | $537.85 | 2022-2025 | |
| Lilly USA, LLC | $477.67 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Novartis Pharmaceuticals Corporation | $393.61 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $359.11 | 2023-2025 | Hyqvia, Trintellix |
| Otsuka America Pharmaceutical, INC. | $355.84 | 2022-2025 | Rexulti, Nuedexta |
| Boston Scientific Corporation | $329.59 | 2023-2025 | Vercise |
| Jazz Pharmaceuticals INC. | $304.40 | 2023-2025 | |
| Eisai INC. | $295.50 | 2022-2025 | |
| Argenx US, INC. | $237.58 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $234.65 | 2025 | Symbravo |
| Celgene Corporation | $233.17 | 2023-2025 | Zeposia |
| Emd Serono, INC. | $225.52 | 2023-2025 | Mavenclad |
| Lundbeck LLC | $177.18 | 2023-2025 | Vyepti, Rexulti |
| Biogen, INC. | $176.32 | 2023-2025 | Vumerity, Tysabri, Skyclarys |
| Sk Life Science, INC. | $174.51 | 2022-2023 | |
| Harmony Biosciences LLC | $165.50 | 2023 | Wakix |
| Acadia Pharmaceuticals INC | $145.26 | 2022-2025 | Nuplazid |
| Supernus Pharmaceuticals, INC. | $121.23 | 2024 | Qelbree |
| Grifols USA, LLC | $117.05 | 2024-2025 | Gamunex-C |
| Alnylam Pharmaceuticals INC. | $111.10 | 2022-2024 | Onpattro |
| Acorda Therapeutics, INC | $103.18 | 2022-2024 | Inbrija, Ampyra |
| Genentech USA, INC. | $96.06 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Tanabe Pharma America, INC. | $94.13 | 2022-2024 | |
| Janssen Biotech, INC. | $91.26 | 2025 | |
| Zoll Respicardia, INC. | $89.77 | 2025 | Remede System |
| Sumitomo Pharma America, INC. | $80.85 | 2023-2024 | Aptiom |
| Neurelis, INC. | $80.02 | 2022-2023 | Valtoco |
| Sunovion Pharmaceuticals INC. | $71.09 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.65 | 2023-2024 | Zeposia |
| Avion Pharmaceuticals | $66.62 | 2022-2023 | Dhivy |
| Avanir Pharmaceuticals, INC. | $65.36 | 2022 | |
| Amneal Pharmaceuticals LLC | $60.31 | 2023-2024 | Rytary, Ongentys |
| Alexion Pharmaceuticals, INC. | $54.13 | 2022-2024 | Ultomiris |
| Idorsia Pharmaceuticals US INC | $52.81 | 2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $51.19 | 2023 | Hetlioz |
| Biohaven Pharmaceutical Holding Company LTD. | $40.96 | 2022 | |
| Amgen INC. | $40.06 | 2023 | Aimovig |
| Csl Behring | $38.44 | 2025 | Hizentra |
| Nevro Corp. | $34.33 | 2023-2024 | Senza |
| Insightec,INC | $33.87 | 2024-2025 | Exablate |
| Livanova USA, INC. | $28.45 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Genzyme Corporation | $26.77 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $25.31 | 2025 | |
| Allergan, INC. | $25.15 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.87 | 2025 | Wainua |
| Merz Pharmaceuticals, LLC | $21.85 | 2023 | Xeomin |
| Kedrion Biopharma, INC. | $19.73 | 2025 | Rhogam Ultra-Filtered Plus, Kedrab, Albuked |
| Inspire Medical Systems, INC. | $18.84 | 2024 | Inspire |
| Kyowa Kirin, INC. | $16.31 | 2022 | |
| Corium, LLC | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.